Literature DB >> 14557856

Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury.

Xiao Su1, Chunxue Bai, Qunying Hong, Duming Zhu, Lixian He, Jianping Wu, Feng Ding, Xiaohui Fang, Michael A Matthay.   

Abstract

OBJECTIVE: This study examined whether continuous hemofiltration favorably affects cardiopulmonary variables, lung inflammation, and lung fluid balance in a canine model of oleic acid induced acute lung injury.
METHODS: Eleven pentobarbital-anesthetized dogs were randomly divided into a control (mechanical ventilation, MV) group (n=6) and a MV plus hemofiltration (HF) group (n=5). All animals received an intravenous injection of oleic acid (0.09 ml/kg) to induce acute lung injury. Continuous arterial-venous hemofiltration (blood flow 100 ml/min, ultrafiltration rate at 50-65 ml kg(-1) h(-1)) was started after establishment of oleic acid induced acute lung injury and continued for 4 h. Hemodynamics, lung mechanics, gas exchange, lung fluid balance, lung histology, and the level of plasma cytokines were assessed.
RESULTS: After 240 min of HF treatment there was a significant increase in cardiac output, reduction in pulmonary arterial pressure, and improvement in both oxygenation and lung mechanics. Also, in the HF group the lung wet-to-dry weight ratio was significantly reduced. Histologically, HF reduced edema and inflammatory cell infiltration in the lung. There was also a significantly greater decrease in plasma IL-6 and IL-8 levels in the HF group than in group receiving MV alone.
CONCLUSIONS: In a canine model of acute lung injury continuous HF improved cardiopulmonary function, reduced pulmonary edema, decreased lung permeability and inflammation, and decreased the plasma concentration of proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557856     DOI: 10.1007/s00134-003-2017-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

1.  Effect of methylprednisolone on phospholipase A(2) activity and lung surfactant degradation in acute lung injury in rabbits.

Authors:  K Kuwabara; S Furue; Y Tomita; M Ueno; T Ono; A Matsukawa; M Yoshinaga; K Mikawa; K Nishina; M Shiga; H Obara; Y Hori
Journal:  Eur J Pharmacol       Date:  2001-12-21       Impact factor: 4.432

2.  Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock.

Authors:  B Stein; E Pfenninger; A Grünert; J E Schmitz; M Hudde
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Effects of inverse ratio ventilation and positive end-expiratory pressure in oleic acid-induced lung injury.

Authors:  P Neumann; J E Berglund; L G Andersson; E Maripu; A Magnusson; G Hedenstierna
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

4.  Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.

Authors:  J H Reeves; W W Butt; F Shann; J E Layton; A Stewart; P M Waring; J J Presneill
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

5.  High-volume haemofiltration in human septic shock.

Authors:  L Cole; R Bellomo; D Journois; P Davenport; I Baldwin; P Tipping
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

Review 6.  Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation.

Authors:  E Abraham; M A Matthay; C A Dinarello; J L Vincent; J Cohen; S M Opal; M Glauser; P Parsons; C J Fisher; J E Repine
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

Review 7.  Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry Coller; Claire M Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur S Slutsky; Kevin J Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin
Journal:  Am J Respir Crit Care Med       Date:  2003-04-01       Impact factor: 21.405

8.  Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury.

Authors:  S Syrbu; R S Thrall; H M Smilowitz
Journal:  Exp Lung Res       Date:  1996 Jan-Feb       Impact factor: 2.459

9.  Effect of veno-venous ultrafiltration on myocardial performance immediately after cardiac surgery in children. A prospective randomized study.

Authors:  E S Rivera; T R Kimball; W W Bailey; S A Witt; P R Khoury; S R Daniels
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

10.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.

Authors:  E J Miller; A B Cohen; S Nagao; D Griffith; R J Maunder; T R Martin; J P Weiner-Kronish; M Sticherling; E Christophers; M A Matthay
Journal:  Am Rev Respir Dis       Date:  1992-08
View more
  21 in total

Review 1.  Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-26       Impact factor: 17.440

Review 2.  Nonventilatory treatments for acute lung injury and ARDS.

Authors:  Carolyn S Calfee; Michael A Matthay
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

3.  Melatonin reduces acute lung inflammation, edema, and hemorrhage in heatstroke rats.

Authors:  Wen-shiann Wu; Ming-ting Chou; Chien-ming Chao; Chen-kuei Chang; Mao-tsun Lin; Ching-ping Chang
Journal:  Acta Pharmacol Sin       Date:  2012-05-21       Impact factor: 6.150

4.  Activation of SIRT1 ameliorates LPS-induced lung injury in mice via decreasing endothelial tight junction permeability.

Authors:  Cuiping Fu; Shengyu Hao; Xiaobo Xu; Jian Zhou; Zilong Liu; Huan Lu; Limin Wang; Weizhong Jin; Shanqun Li
Journal:  Acta Pharmacol Sin       Date:  2018-07-18       Impact factor: 6.150

5.  Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic stem cell transplantation.

Authors:  Lama Elbahlawan; Nancy K West; Yvonne Avent; Cheng Cheng; Wei Liu; Raymond C Barfield; Deborah P Jones; Surender Rajasekaran; R Ray Morrison
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

6.  Priming with endotoxin increases acute lung injury in mice by enhancing the severity of lung endothelial injury.

Authors:  Joyce S Lee; Xiao Su; Craig Rackley; Michael A Matthay; Naveen Gupta
Journal:  Anat Rec (Hoboken)       Date:  2010-11-16       Impact factor: 2.064

7.  The Effects of Portulaca oleracea on Hypoxia-Induced Pulmonary Edema in Mice.

Authors:  Tan Yue; Wen Xiaosa; Qi Ruirui; Shi Wencai; Xin Hailiang; Li Min
Journal:  High Alt Med Biol       Date:  2015-03-11       Impact factor: 1.981

8.  Enhanced expression of Fas and FasL modulates apoptosis in the lungs of severe P. falciparum malaria patients with pulmonary edema.

Authors:  Chuchard Punsawad; Parnpen Viriyavejakul; Chayanee Setthapramote; Sarawoot Palipoch
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Mechanical ventilation and the kidney.

Authors:  Jay L Koyner; Patrick T Murray
Journal:  Blood Purif       Date:  2009-11-19       Impact factor: 2.614

10.  Chronic intermittent hypoxia decreases pulmonary clearance of 99mTc-labelled particulate matter in mice.

Authors:  Cuiping Fu; Huan Lu; Xu Wu; Jie Liu; Chengying Liu; Zilong Liu; Wei Yuan; Jian Zhou; Shanqun Li
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.